Seasonal influenza causes a high disease burden every year in the United States and worldwide. Anticipating epidemic size ahead of season can contribute to preparedness and more targetted control and prevention of seasonal influenza.
H3N2 subtype in the United States, a process-based model (EvoEpiFlu) was recently developed that incorporates evolutionary information into epidemiology based on the mathematical SIRS formulation of transmission dynamics (for Susceptible, Infected, Recovered and Susceptible immune classes in the population) (1, 2) . The SIRS model (without evolutionary change) is being used successfully to implement within-season forecasting (3) . EvoEpiFlu makes additional use of evolutionary information related to antigenic change and based solely on readily available genetic sequences of the virus, to extend the lead time of prediction and make it possible to produce forecasts ahead of the influenza season (1, 2) . There are two versions of the EvoEpiFlu model based respectively on either a continuous or a discrete covariate for evolutionary change. The 'continuous' version of the model relies on an evolutionary index measuring how much the genetic sequences encoding antigenic sites have changed relatively to the recent past. The 'discrete' or 'cluster' version relies instead on the proportion of antigenic variants (PAV) inferred on the basis of an existing genotype-phenotype map (4), to identify intermittent periods of antigenic change (1, 2) . An increasing and high value of either measure of evolutionary change indicates the emergence of novel variants and a potential for high levels of future infection. A decreasing trend for PAV implies similar circulating strains and potentially fewer infections due to immune protection (1, 2) . Similarly, a decrease from sustained high values of the evolutionary index would preclude a high number of susceptible individuals and reduce transmission (1, 2) .
Based on the EvoEpiFlu model, we had previously generated a prediction for the 2017-2018 influenza season before it arrived, which we can now be validated with the updated surveillance data (Figure 1 , bottom panel). The prediction was a high H3N2 season with an estimated higher than median incidence rate (proportion of the population infected) of 0.09 ([0.05,0.14], 95% confidence interval) ( Figure 1 , dotted black curve and shaded black area, bottom panel). For comparison, the observed average incidence rate of H3N2 for the past sixteen years is 0.06 . Our prediction is consistent with an observed value of 0.14 for the season that just ended (5) , with the actual rate higher than median and within, but at the higher limit, of our prediction interval ( Figure 1 , bottom panel, solid black curve).
Encouraged by the prediction skill of EvoEpiFlu in this last season and before (1,2), we report here a routine forecast for the upcoming 2018-2019 influenza season. Both the PAV and the Evolutionary Index, exhibit a decreasing trend (Figure 1 , top 2 panels). On the basis of this trend in PAV and the incidence data up to June 2018, EvoEpiFlu's cluster model predicts that the upcoming 2018-2019 season will be H3N2 low, with an estimated median incidence rate of 0.013 ([0.003,0.041], 95% confidence interval) (Figure 1, bottom (Figure 1, bottom panel) exhibit however a significant negative correlation (Spearman correlation of -0.64, p-value < 0.01), and H3N2 and B, a positive one (Spearman correlation of 0.58, p-value < 0.05). Additionally, we did not observe any novel antigenic change for either H1N1 or B in the last three years based on the PAV analysis (PAV < 0.1) (4,6). As a result, with a forecast of low H3N2 (median incidence rate 0.01) for the upcoming 2018/2019 season in the United States, we would expect a higher than average level for H1N1, and a lower than average level for B. For reference, the mean incidence rate of H1N1 was 0.10, and the mean value for B was 0.02 ( based on the only two pandemic H1N1-dominant seasons of 2013/2014 and 2015/2016).
Although we correctly predicted an H3N2-dominant season for the past season that just ended, its observed incidence rate was more severe than our mean prediction (2, 5) . Also, the continuous model consistently predicts higher incidence rates than the cluster model, and has a tendency to overpredict (1) . This indicates that there is room for improvement of EvoEpiFlu, to better incorporate information on antigenic change and to include other important information on vaccination and climate covariates. Future work is also needed to implement similar process-based dynamical models for the other subtype of seasonal influenza A and for type B. Type B influenza in particular has been less studied, including the dynamics between its two lineages and their the interaction with type A . Although the PAV values are low (<0.1) for both the Yamagata and Victoria lineages of influenza B, the CDC influenza surveillance system has captured novel antigenic variants in the Victoria lineage (5, 7) . Based on the observation that the Victoria lineage as a whole is declining (from 30% in the 2016-2017 season to 11% in the 2017-2018 season) among influenza B (5,7), we do not expect however an expansion and a high incidence rate for either the Victoria lineage or influenza B as a whole. Ideally, a multi-subtype model could be developed and evaluated for comprehensive forecasts of seasonal influenza in the United States, and potentially for better control and prevention.
